A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma – the STRONG study: study protocol for a randomised controlled trial
© The Author(s). 2017
Received: 27 October 2016
Accepted: 20 February 2017
Published: 16 March 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|27 Oct 2016||Submitted||Original manuscript|
|28 Oct 2016||Author responded||Author comments - Katrin Lorenz|
|Resubmission - Version 2|
|28 Oct 2016||Submitted||Manuscript version 2|
|20 Feb 2017||Reviewed||Reviewer Report - Marion Munk|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|20 Feb 2017||Editorially accepted|
|16 Mar 2017||Article published||10.1186/s13063-017-1861-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.